A recent expedition by researchers from the University of South Florida (USF) to Antarctica has advanced the study of a marine organism that may lead to new treatments for melanoma, a severe form of skin cancer. The expedition focused on a species of ascidian, or sea squirt, which contains a bacterium capable of killing melanoma cells while sparing normal human cells. This discovery, initially made by USF professor Bill Baker two decades ago, highlights the potential of natural sources in drug development. The unique Antarctic environment, where these organisms have evolved independently, offers insights into their chemical defenses. During the six-week expedition, researchers collected samples from depths of 18 to 24 meters, utilizing remotely operated vehicles and careful dive planning to ensure safety and sample integrity. The research now enters a critical phase, with teams analyzing the specimens for DNA, chemistry, and biological properties. This work could ultimately lead to new therapies for complex diseases like melanoma, emphasizing the importance of understanding symbiotic relationships in extreme ecosystems.